Volpara Health Technologiesの資産のリターン
Volpara Health Technologiesの資産のリターン は何ですか。
Volpara Health Technologies Limitedの資産のリターン は-11.20%です。
資産のリターン の定義は何ですか。
資産のリターンは 、企業の資産が収益を生み出す際の収益性を示します。純利益を平均総資産で除して計算されます。
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
ASXのセクタHealth Careにおける資産のリターン の企業と比べるVolpara Health Technologies
Volpara Health Technologiesは何をしますか。
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Volpara Health Technologiesと類似の資産のリターン
- Eden Research plcの資産のリターン は-11.23%です。
- Barnwell Industriesの資産のリターン は-11.23%です。
- Giga Metalsの資産のリターン は-11.21%です。
- GIGA Metalsの資産のリターン は-11.21%です。
- China Eastern Airlinesの資産のリターン は-11.20%です。
- China Environmental Resourcesの資産のリターン は-11.20%です。
- Volpara Health Technologiesの資産のリターン は-11.20%です。
- True North Gemsの資産のリターン は-11.19%です。
- International Travel Houseの資産のリターン は-11.19%です。
- Million Starsの資産のリターン は-11.19%です。
- Harrow Healthの資産のリターン は-11.19%です。
- Aurexの資産のリターン は-11.19%です。
- Abacus Mining & Explorationの資産のリターン は-11.19%です。